lundi 17 septembre 2012

Recently adopted names for antitumoral compounds (September 2012) - Noms d’antitumoraux adoptés récemment (septembre 2012)





Name (nom)
Code name
Type
Target(s)




INNO-206
An albumin-binding doxorubicin prodrug
DNA intercalator
CBLB502
Protein
Radiation countermeasure drug
Nelipepimut-S (NeuVax)
E75 peptide
Peptide (vaccine)
HER2/neu
MSC1936369A; AS703026; EMD 1036239
Synthetic small molecule inhibitor
MEK1
IMC-1121B
Monoclonal antibody
VEGFR-2
DP-1919.TO, DCC-2036
Synthetic small molecule inhibitor
Multiple tyrosine kinases


Aucun commentaire:

Enregistrer un commentaire